A new research paper offers the most thorough look yet at a study that sparked the drug industry’s recent experimentation with cell therapy for autoimmune diseases.
The paper, which was published in The New England Journal of Medicine on Wednesday, comes from a team of scientists at the Friedrich Alexander University, Erlangen-Nurnberg in Germany. They detail how 15 people with severe autoimmune conditions experienced either disease remission or a sharp reduction in symptoms after an infusion of a kind of cell therapy known as CAR-T.
